SilverCape Lowers Takeover Offer for PetMed to $3/Share Citing Business Decline
PetMed’s board will review the lowered offer.
Already have an account? Sign in.
PetMed’s board will review the lowered offer.
The FDA says an Evolus Instagram post overstated Jeuveau benefits and downplayed risks. The firm has 15 working days to respond.
Novartis will pay $575 million upfront for worldwide rights to Abogen's mRNA T-cell engager, plus up to $7.2 billion in milestones.
Planet Labs put 20 satellites in orbit on Oct. 1, 2026, including a Google TPU prototype, Tanager-2 methane sensor, and 18 SuperDoves.